Aetna modified CPB 0644 for orthopoxvirus vaccines (smallpox and mpox), effective December 17, 2025. Here's what billing teams need to know before submitting claims.
Aetna, a CVS Health company, updated its orthopoxvirus vaccine coverage policy under CPB 0644 in the Aetna system. The policy governs reimbursement for CPT 90611 (JYNNEOS, the mpox/smallpox vaccine) and CPT 90622 (vaccinia smallpox vaccine). If your practice bills immunization services for high-risk populations, occupational health programs, or public health response teams, this policy change affects your charge capture and medical necessity documentation.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna, a CVS Health company |
| Policy | Orthopoxvirus Vaccines |
| Policy Code | CPB 0644 |
| Change Type | Modified |
| Effective Date | December 17, 2025 |
| Impact Level | Medium |
| Specialties Affected | Infectious Disease, Occupational Health, Public Health, Primary Care, Sexual Health Clinics |
| Key Action | Audit your ICD-10 diagnosis codes against the updated eligibility criteria before billing CPT 90611 or 90622 |
Aetna Orthopoxvirus Vaccine Coverage Criteria and Medical Necessity Requirements 2025
The Aetna orthopoxvirus vaccine coverage policy splits into two distinct vaccines — smallpox and mpox — each with its own medical necessity criteria. These are not interchangeable. Make sure your documentation maps to the right bucket.
Smallpox Vaccine (CPT 90622)
Aetna covers the smallpox vaccine for pre-exposure immunization when public health authorities advise vaccination is necessary. The CDC's Advisory Committee on Immunization Practices (ACIP) currently limits pre-exposure recommendations to three groups:
| # | Covered Indication |
|---|---|
| 1 | Laboratory workers who directly handle non-highly attenuated smallpox virus cultures, materials, or infected animals |
| 2 | Persons pre-designated by public health authorities to conduct investigation and follow-up of initial smallpox cases requiring direct patient contact |
| 3 | Selected personnel at facilities pre-designated as referral centers for initial smallpox cases |
Aetna also covers the smallpox vaccine for post-exposure scenarios — persons who have or may have been recently exposed to smallpox or non-highly attenuated vaccinia virus. This is a hard coverage trigger. If exposure is documented, the claim has a strong medical necessity basis.
Re-vaccination is covered as frequently as every three years for qualifying personnel.
What's not covered: Smallpox vaccination of the general population. Aetna follows ACIP guidance here. Because the risk of intentional smallpox release is currently considered low, the potential benefits of routine vaccination do not outweigh the risks of vaccine complications. Billing CPT 90622 for a general-population patient without qualifying occupational or exposure criteria is a fast path to a claim denial.
Mpox Vaccine (CPT 90611)
The mpox vaccine criteria are broader and more nuanced. Aetna covers the 2-dose JYNNEOS series (CPT 90611) when a person meets any of the following:
| # | Covered Indication |
|---|---|
| 1 | Known or suspected exposure to someone with mpox |
| 2 | A sex partner diagnosed with mpox in the past 14 days |
| 3 | Gay, bisexual, men who have sex with men (MSM), or transgender/nonbinary/gender-diverse persons who in the past six months had any of: a new STI diagnosis (chlamydia, gonorrhea, or syphilis), more than one sex partner, sex at a commercial sex venue, or sex at a large public event in an area with active mpox transmission |
| 4 | A sex partner with any of the above risks |
| 5 | Anticipated exposure to any of the above scenarios |
| 6 | Occupational risk — certain laboratory workers or healthcare workers |
The ACIP language around "anticipates experiencing" any covered scenario is notable. It creates a pre-exposure pathway that's broader than the smallpox criteria. Document patient-reported risk factors carefully. The ICD-10 codes Z72.51 (high risk heterosexual behavior), Z72.52 (high risk homosexual behavior), and Z72.53 (high risk bisexual behavior) are the natural companions for this group. Use them.
Prior authorization: The policy does not explicitly list prior authorization requirements for these vaccines in the covered summary. That said, your Aetna plan contracts may impose prior auth for specific plan types. Verify with your plan-level benefits setup — especially for commercial fully-insured plans versus ASO accounts — before assuming these are auto-covered. If you're unsure how this applies to your payer mix, loop in your compliance officer before the December 17, 2025 effective date.
Aetna Orthopoxvirus Vaccine Exclusions and Non-Covered Indications
Aetna is direct about one major exclusion: routine smallpox vaccination of the general population has no proven value and is not covered. The policy language cites ACIP guidance specifically — vaccination risks outweigh benefits when there's no active public health emergency.
Beyond that, the policy includes several clinical notes that function as soft exclusions from a billing standpoint:
| # | Excluded Procedure |
|---|---|
| 1 | Tuberculin skin test (TST): Do not perform a TST within four weeks of smallpox vaccination. If a patient gets both billed in the same window, expect scrutiny. Use CPT 86580 cautiously in post-vaccination encounters. |
| 2 | Breastfeeding: Smallpox vaccination of a breastfeeding mother is contraindicated due to theoretical contact transmission risk. Document this contraindication if it's a factor in clinical decision-making — it affects which claims you can defend. |
| 3 | Assisted reproductive technology donors: Persons who recently received the smallpox vaccine should be deferred as ART donors. This is a clinical note with no direct billing consequence, but it's relevant if your practice intersects with fertility medicine. |
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Smallpox vaccine — occupational pre-exposure (lab workers, designated response personnel) | Covered | CPT 90622, Z23 | Must meet ACIP occupational or public health criteria |
| Smallpox vaccine — post-exposure (known or suspected smallpox exposure) | Covered | CPT 90622, Z20.89 | Exposure must be documented |
| Smallpox vaccine — general population (no exposure or occupational risk) | Not Covered | CPT 90622 | ACIP does not recommend; claim denial risk is high |
| Mpox vaccine (JYNNEOS) — known or suspected mpox exposure | Covered | CPT 90611, Z20.89 | 2-dose series |
| Mpox vaccine — sex partner with recent mpox diagnosis (past 14 days) | Covered | CPT 90611, Z20.2 | Document partner diagnosis |
| Mpox vaccine — MSM/transgender/nonbinary with qualifying STI or behavior risk in past 6 months | Covered | CPT 90611, Z72.52, Z72.53, A50.01–A63.8 | STI diagnosis codes from A50.01–A63.8 support the claim |
| Mpox vaccine — anticipated high-risk exposure | Covered | CPT 90611, Z72.51–Z72.53 | Patient-reported anticipation of risk qualifies |
| Mpox vaccine — occupational risk (lab workers, healthcare workers handling orthopoxviruses) | Covered | CPT 90611, Z23 | Occupational exposure must be documented |
| Tuberculin skin test within 4 weeks of smallpox vaccination | Not Covered / Avoid | CPT 86580 | Clinical contraindication; claim scrutiny likely |
| General smallpox vaccination (no qualifying criteria) | Not Covered | CPT 90622 | No proven value per ACIP; deny risk high |
Aetna Orthopoxvirus Vaccine Billing Guidelines and Action Items 2025
These are concrete steps for your billing team. Prioritize them before December 17, 2025.
| # | Action Item |
|---|---|
| 1 | Update your charge capture templates for CPT 90611 and 90622. Both codes are covered only when selection criteria are met. If your EHR or billing system has these on a standard immunization order set without criteria prompts, add a documentation requirement. A clean claim for orthopoxvirus vaccine billing starts at the point of order entry — not at claim submission. |
| 2 | Map your ICD-10 codes to specific criteria, not just to the vaccine administered. Z23 works for pre-exposure occupational immunization. Z20.89 works for exposure scenarios. Z72.51, Z72.52, and Z72.53 support mpox pre-exposure for behavioral risk groups. STI diagnosis codes in the A50.01–A63.8 range support coverage when a recent STI diagnosis is the qualifying factor. Don't default to Z23 for everything — it won't hold up if the patient's qualifying factor is behavioral risk, not occupational. |
| 3 | Audit your immunization administration codes. For patients 18 and under, pair CPT 90611 or 90622 with CPT 90460 (with counseling) and CPT 90461 (additional components). For adults, use CPT 90471 and CPT 90472 for each additional vaccine. Make sure counseling documentation supports 90460 when billed for pediatric patients. |
| 4 | Don't bill CPT 86580 (TST) within four weeks of smallpox vaccination. This is a clinical rule with a billing consequence. If your workflow auto-orders a TST at the same encounter, flag this in your charge review process. A TST billed too soon after smallpox vaccination may get denied or flagged for a medical necessity review. |
| 5 | Verify prior authorization requirements at the plan level. The CPB 0644 coverage policy in the Aetna system doesn't spell out blanket prior auth requirements for these vaccines — but specific plan documents may. ASO (self-funded) plans in particular can carve this out. Before December 17, 2025, pull your top Aetna plan contracts and check. If your compliance officer or billing consultant isn't already tracking this, now is the time to assign it. |
| 6 | Document occupational exposure specifics for smallpox vaccine claims. "Lab worker" alone won't hold up a claim audit. Document the nature of the work, the virus materials involved, and the connection to a facility pre-designated for smallpox response. This is the difference between a paid claim and a post-payment audit recoupment. |
| 7 | Use CPT 87593 for diagnostic testing when relevant. If your practice handles orthopoxvirus detection (nucleic acid testing for monkeypox, cowpox, or related viruses), CPT 87593 is listed as a related code under CPB 0644. Keep your diagnostic and vaccine billing in sync when a patient has both a diagnostic workup and a vaccination in the same episode. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Orthopoxvirus Vaccines Under CPB 0644
Covered CPT Codes (When Selection Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| 90611 | CPT | Smallpox and monkeypox vaccine, attenuated vaccinia virus, live, non-replicating, preservative free (JYNNEOS) |
| 90622 | CPT | Vaccinia (smallpox) virus vaccine, live, lyophilized, 0.3 mL dosage, for percutaneous use |
Key ICD-10-CM Diagnosis Codes
| Code | Description |
|---|---|
| A50.01–A63.8 | Infections with a predominantly sexual mode of transmission (supports mpox vaccine coverage when STI diagnosis is the qualifying factor) |
| Z20.2 | Contact with and suspected exposure to infections with a predominantly sexual mode of transmission |
| Z20.89 | Contact with and suspected exposure to other communicable diseases — applicable for smallpox and monkeypox exposure |
| Z23 | Encounter for immunization — use for pre-exposure occupational vaccination; see criteria |
| Z72.51 | High risk heterosexual behavior |
| Z72.52 | High risk homosexual behavior |
| Z72.53 | High risk bisexual behavior |
Get the Full Picture for CPT 90611
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.